and joined the MJH Life Sciences team in April 2021. She graduated from Kent State University in 2018 with a bachelor's degree in journalism and a minor in sociology. Linda used to work as a creative writer for 

 and was a technical writer/regulatory specialist/purchasing agent at GM Industrial before coming on to the team. She enjoys reading, traveling, and learning new perspectives. You can reach her at 

 editorial board member and physician-scientist practicing general medical and surgical dermatology at Yale University, in New Haven, Connecticut, dives into the acne drug pipeline. Hear his notes on what potenital new treatments are coming for acne vulgaris, exciting research advancements in the space, and much more. 

Acne 

Expert Perspectives

Zits. Pimples. Nearly 90% of Americans will experience at least minor acne breakouts at some time in their lives. They are all too familiar with the bumps and redness associated with even mild disease. However, many are still unaware of the true physical and psychological burden of this challenging condition.

Dermatology Times® developed this exclusive Consortium on Acne Awareness to fill this information gap and accelerate the journey from care to cure. This dynamic tool showcase advances in therapies and modalities, innovative clinical pearls, statistics, and research that are major steps in combatting the nation’s most widespread skin condition.

Continually updated, this resource is a nexus not only for news and expert advice from leaders in the specialty, but also from visionaries in adjunct fields from nutrition to mental health and plastic and reconstructive surgery. Must-see headline briefs, articles, podcasts, and videos keep the specialty’s medical professionals at the cutting edge of holistic patient care.

Acne Awareness

Consortium

In this drug pipeline interview, Christopher Bunick, MD, PhD, discusses what is innovative in future acne treatment options, what research is happening, and what potential approvals the dermatology space has to look forward to. 

Drug Watch: What's Coming in Acne Treatment?